Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Augustin

Showing results (261-270 of 491) with videos related to

Pageof 50
Sort By:
Dermatology and Therapy|March 31, 2021
Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysisApril W Armstrong, Ahmed M Soliman, Keith A Betts, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 19, 2011
Therapy of psoriasis in childhood and adolescence - a German expert consensusMichael Sticherling, Matthias Augustin, Wolf-Henning Boehncke, et al.
Acta Dermato-Venereologica|June 1, 2016
Cost-effectiveness of an 8% Capsaicin Patch in the Treatment of Brachioradial Pruritus and Notalgia Paraesthetica, Two Forms of Neuropathic PruritusSabine Steinke, Mandy Gutknecht, Claudia Zeidler, et al.
Experimental Dermatology|May 18, 2022
Registries, multicentre and genome-wide association studies in hidradenitis suppurativaGregor B E Jemec, Véronique Del Marmol, Vincenzo Bettoli, et al.
Clinical, Cosmetic and Investigational Dermatology|November 29, 2023
Learning from the Experiences in the COVID-19 Pandemic - Impact on Quality of Life and Challenges for the Staff of a Dermatological Hospital and Rehabilitation Center in Germany: A Retrospective AnalysisLorenz Julius Kuhls, Jeta Demiri, Adam Weidlich, et al.
The Journal of Dermatological Treatment|February 4, 2021
Exploring determinants of psoriasis patients' treatment choices: a discrete-choice experiment study in the United States and GermanySteven R Feldman, Christine Poulos, Isabelle Gilloteau, et al.
Dermatology (Basel, Switzerland)|June 19, 2010
Time needed for treatment is the major predictor of quality of life in psoriasisChristine Blome, Stefan Simianer, Sandra Purwins, et al.
The Journal of Dermatological Treatment|November 2, 2010
Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: results from PHOENIX 2Kristian Reich, Brad Schenkel, Ning Zhao, et al.
Journal of Wound Care|December 12, 2019
Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcersRalf Lobmann, Matthias Augustin, Holger Lawall, et al.
Dermatology and Therapy|October 23, 2025
Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic DermatitisMatthias Augustin, April Armstrong, Naiem T Issa, et al.
Pageof 50

Showing results (261-270 of 491) with videos related to

Sort By:
Pageof 50
Dermatology and Therapy|March 31, 2021
Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysisApril W Armstrong, Ahmed M Soliman, Keith A Betts, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 19, 2011
Therapy of psoriasis in childhood and adolescence - a German expert consensusMichael Sticherling, Matthias Augustin, Wolf-Henning Boehncke, et al.
Acta Dermato-Venereologica|June 1, 2016
Cost-effectiveness of an 8% Capsaicin Patch in the Treatment of Brachioradial Pruritus and Notalgia Paraesthetica, Two Forms of Neuropathic PruritusSabine Steinke, Mandy Gutknecht, Claudia Zeidler, et al.
Experimental Dermatology|May 18, 2022
Registries, multicentre and genome-wide association studies in hidradenitis suppurativaGregor B E Jemec, Véronique Del Marmol, Vincenzo Bettoli, et al.
Clinical, Cosmetic and Investigational Dermatology|November 29, 2023
Learning from the Experiences in the COVID-19 Pandemic - Impact on Quality of Life and Challenges for the Staff of a Dermatological Hospital and Rehabilitation Center in Germany: A Retrospective AnalysisLorenz Julius Kuhls, Jeta Demiri, Adam Weidlich, et al.
The Journal of Dermatological Treatment|February 4, 2021
Exploring determinants of psoriasis patients' treatment choices: a discrete-choice experiment study in the United States and GermanySteven R Feldman, Christine Poulos, Isabelle Gilloteau, et al.
Dermatology (Basel, Switzerland)|June 19, 2010
Time needed for treatment is the major predictor of quality of life in psoriasisChristine Blome, Stefan Simianer, Sandra Purwins, et al.
The Journal of Dermatological Treatment|November 2, 2010
Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: results from PHOENIX 2Kristian Reich, Brad Schenkel, Ning Zhao, et al.
Journal of Wound Care|December 12, 2019
Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcersRalf Lobmann, Matthias Augustin, Holger Lawall, et al.
Dermatology and Therapy|October 23, 2025
Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic DermatitisMatthias Augustin, April Armstrong, Naiem T Issa, et al.
Pageof 50